Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Stock Options Outstanding by Year
Stock Options Outstanding — Aggregate Intrinsic Value ($M) ($M)
Natera Stock Options Outstanding: $725M in FY2025, up 46.2% from a year earlier. That is the highest of the 9 years on record here.
Latest, FY2025
725
Period ended Dec 31, 2025
Change on a year earlier
+46.2%
496 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K Note — Stock-Based Compensation (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Stock Options Outstanding — Aggregate Intrinsic Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 725 | +46.2% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 496 | +114.7% | Form 10-K (2026-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 231 | +75.9% | Form 10-K (2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 131 | -70.9% | Form 10-K (2024-02-29) ↗ |
| FY2021 | Dec 31, 2021 | 452 | -23.8% | Form 10-K (2023-03-01) ↗ |
| FY2020 | Dec 31, 2020 | 592 | +199.3% | Form 10-K (2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 198 | +220.7% | Form 10-K (2021-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 61.7 | +93.5% | Form 10-K (2020-03-02) ↗ |
| FY2017 | Dec 31, 2017 | 31.9 | – | Form 10-K (2019-03-15) ↗ |
Cite this data
StockData. (2026). Natera Stock Options Outstanding ($M), annual FY2017–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/equity-options-outstanding-intrinsic-val
See every metric in the Natera KPI table. Data updated Nov 2, 2026.